{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT05060432",
      "orgStudyIdInfo": {
        "id": "TIG-006"
      },
      "organization": {
        "fullName": "iTeos Therapeutics",
        "class": "INDUSTRY"
      },
      "briefTitle": "Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors",
      "officialTitle": "A Multicenter, Open-Label, Phase I/II Study of EOS884448 (EOS-448) in Combination With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors",
      "acronym": "TIG-006"
    },
    "statusModule": {
      "statusVerifiedDate": "2024-06",
      "overallStatus": "ACTIVE_NOT_RECRUITING",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2021-09-06",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2024-07",
        "type": "ESTIMATED"
      },
      "completionDateStruct": {
        "date": "2025-07",
        "type": "ESTIMATED"
      },
      "studyFirstSubmitDate": "2021-09-06",
      "studyFirstSubmitQcDate": "2021-09-27",
      "studyFirstPostDateStruct": {
        "date": "2021-09-29",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2024-06-19",
      "lastUpdatePostDateStruct": {
        "date": "2024-06-21",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "iTeos Belgium SA",
        "class": "INDUSTRY"
      },
      "collaborators": [
        {
          "name": "GlaxoSmithKline",
          "class": "INDUSTRY"
        },
        {
          "name": "iTeos Therapeutics",
          "class": "INDUSTRY"
        }
      ]
    },
    "oversightModule": {
      "oversightHasDmc": true,
      "isFdaRegulatedDrug": true,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "This is a multicenter, open-label, phase I/II basket study, evaluating the safety, tolerability, RP2D, pharmacokinetics, pharmacodynamics and antitumor activity of EOS-448 (also known as GSK4428859A or belrestotug) combined with standard of care and/or with investigational therapies in participants with advanced solid tumors.",
      "detailedDescription": "The combinations evaluated will be:\n\n* EOS-448 combined with pembrolizumab, an anti-PD-1 antibody\n* EOS-448 combined with inupadenant an investigational adenosine A2A receptor antagonist\n* EOS-448 combined with dostarlimab an anti-PD-1 antibody\n* inupadenant combined with dostarlimab\n* EOS-448 combined with inupadenant and dostarlimab\n* EOS-448 combined with dostarlimab and standard of care chemotherapies in participants with NSCLC"
    },
    "conditionsModule": {
      "conditions": [
        "Advanced Cancer",
        "Lung Cancer",
        "Head and Neck Cancer",
        "Melanoma"
      ],
      "keywords": [
        "EOS884448",
        "GSK4428859A",
        "TIGIT",
        "Anti-TIGIT",
        "EOS-448",
        "pembrolizumab",
        "dostarlimab",
        "inupadenant",
        "A2A Receptor antagonist",
        "EOS-850",
        "EOS100850",
        "Anti-PD-1 monoclonal antibody",
        "belrestotug"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE1",
        "PHASE2"
      ],
      "designInfo": {
        "allocation": "NON_RANDOMIZED",
        "interventionModel": "SEQUENTIAL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "NONE"
        }
      },
      "enrollmentInfo": {
        "count": 153,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Part 1A - EOS-448 + pembrolizumab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive EOS-448 and pembrolizumab at every cycle",
          "interventionNames": [
            "Drug: EOS-448",
            "Drug: pembrolizumab"
          ]
        },
        {
          "label": "Part 1B - EOS-448 + inupadenant",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive EOS-448 at every cycle and inupadenant on an ongoing basis",
          "interventionNames": [
            "Drug: EOS-448",
            "Drug: inupadenant"
          ]
        },
        {
          "label": "Part 1C - EOS-448 + inupadenant",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive EOS-448 at every cycle and inupadenant on an ongoing basis",
          "interventionNames": [
            "Drug: EOS-448",
            "Drug: inupadenant"
          ]
        },
        {
          "label": "Part 1D - EOS-448 + dostarlimab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive EOS-448 and dostarlimab at every cycle",
          "interventionNames": [
            "Drug: EOS-448",
            "Drug: Dostarlimab"
          ]
        },
        {
          "label": "Part 1E - inupadenant HCl + dostarlimab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive dostarlimab at every cycle and inupadenant on an ongoing basis",
          "interventionNames": [
            "Drug: inupadenant",
            "Drug: Dostarlimab"
          ]
        },
        {
          "label": "Part 1F - EOS-448 + dostarlimab + inupadenant HC",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive EOS-448 and dostarlimab at every cycle and inupadenant on an ongoing basis",
          "interventionNames": [
            "Drug: EOS-448",
            "Drug: inupadenant",
            "Drug: Dostarlimab"
          ]
        },
        {
          "label": "Part 1G - EOS-448 + dostarlimab + chemotherapies",
          "type": "EXPERIMENTAL",
          "description": "Participants with 1L mNSCLC will receive EOS-448 and dostarlimab and chemotherapies at every cycle",
          "interventionNames": [
            "Drug: EOS-448",
            "Drug: Dostarlimab",
            "Drug: SOC chemotherapies"
          ]
        },
        {
          "label": "Part 2C - EOS-448 + dostarlimab",
          "type": "EXPERIMENTAL",
          "description": "Participants with 1L mHNSCC CPS ≥ 20 will receive EOS-448 and dostarlimab at every cycle",
          "interventionNames": [
            "Drug: EOS-448",
            "Drug: Dostarlimab"
          ]
        },
        {
          "label": "Part 2D - EOS-448 + dostarlimab",
          "type": "EXPERIMENTAL",
          "description": "Participants with 1L mHNSCC 1 \\< CPS \\< 20 will receive EOS-448 and dostarlimab at every cycle",
          "interventionNames": [
            "Drug: EOS-448",
            "Drug: Dostarlimab"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "EOS-448",
          "description": "Anti-TIGIT monoclonal antibody",
          "armGroupLabels": [
            "Part 1A - EOS-448 + pembrolizumab",
            "Part 1B - EOS-448 + inupadenant",
            "Part 1C - EOS-448 + inupadenant",
            "Part 1D - EOS-448 + dostarlimab",
            "Part 1F - EOS-448 + dostarlimab + inupadenant HC",
            "Part 1G - EOS-448 + dostarlimab + chemotherapies",
            "Part 2C - EOS-448 + dostarlimab",
            "Part 2D - EOS-448 + dostarlimab"
          ],
          "otherNames": [
            "EOS884448",
            "GSK4428859",
            "belrestotug"
          ]
        },
        {
          "type": "DRUG",
          "name": "pembrolizumab",
          "description": "Anti-PD-1 monoclonal antibody",
          "armGroupLabels": [
            "Part 1A - EOS-448 + pembrolizumab"
          ]
        },
        {
          "type": "DRUG",
          "name": "inupadenant",
          "description": "A2A receptor antagonist",
          "armGroupLabels": [
            "Part 1B - EOS-448 + inupadenant",
            "Part 1C - EOS-448 + inupadenant",
            "Part 1E - inupadenant HCl + dostarlimab",
            "Part 1F - EOS-448 + dostarlimab + inupadenant HC"
          ],
          "otherNames": [
            "EOS100850"
          ]
        },
        {
          "type": "DRUG",
          "name": "Dostarlimab",
          "description": "Anti-PD-1 monoclonal antibody",
          "armGroupLabels": [
            "Part 1D - EOS-448 + dostarlimab",
            "Part 1E - inupadenant HCl + dostarlimab",
            "Part 1F - EOS-448 + dostarlimab + inupadenant HC",
            "Part 1G - EOS-448 + dostarlimab + chemotherapies",
            "Part 2C - EOS-448 + dostarlimab",
            "Part 2D - EOS-448 + dostarlimab"
          ]
        },
        {
          "type": "DRUG",
          "name": "SOC chemotherapies",
          "description": "SOC chemotherapies in 1L mNSCLC",
          "armGroupLabels": [
            "Part 1G - EOS-448 + dostarlimab + chemotherapies"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Percentage of participants with DLT and Adverse Events",
          "timeFrame": "From first study treatment administration through Day 21-28 for DLT / Up to 120 days after the last dose"
        },
        {
          "measure": "Recommended Phase 2 dose (RP2D) of EOS884448 in participants with advanced solid tumors",
          "timeFrame": "Up to 48 weeks"
        },
        {
          "measure": "Percentage of participants with Objective Response as determined by Investigator",
          "timeFrame": "Until disease progression - Approximately 48 months"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Duration of Response (DOR)",
          "timeFrame": "Until disease progression or death - Approximately 48 months"
        },
        {
          "measure": "Disease Control Rate (DCR)",
          "timeFrame": "Until disease progression or death - Approximately 48 months"
        },
        {
          "measure": "Progression-free-survival (PFS)",
          "timeFrame": "Until disease progression or death - Approximately 48 months"
        },
        {
          "measure": "Mean and median Maximum concentration (Cmax) of EOS884448 at each dose level",
          "timeFrame": "Up to 48 weeks"
        },
        {
          "measure": "Percentage of participants with anti-drug antibodies to EOS884448",
          "timeFrame": "Up to 48 weeks"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Provide a signed written informed consent for the trial\n* Have measurable disease, per RECIST v1.1\n* Have an Eastern Cooperative Oncology Group (ECOG) performance status of Grade 0 or 1.\n* Have adequate organ functions\n* Part 1A/1B/1C/1D/1E/1F: Have histologically or cytologically confirmed advanced or metastatic solid tumor for whom no standard treatment with survival benefit is available\n\nPart 1G (NSCLC):\n\n* Have a histologically confirmed or cytologically confirmed previously untreated stage IV OR stage III not amenable to curative chemoradiotherapy or surgery (AJCC 8th edition) nonsquamous NSCLC OR squamous NSCLC.\n* Are eligible to receive anti-PD(L)1 therapy combined with chemotherapy in first line metastatic setting\n\nPart 2 (H\\&N cancer)\n\n* Have histologically or cytologically confirmed recurrent advanced or metastatic head and neck squamous cell carcinoma considered incurable by local therapies\n* PD-L1 status positive\n\nExclusion Criteria:\n\n* Have received any anti-cancer therapy within 4 weeks prior to the first dose\n* Have received a live vaccine within 30 days prior to the first dose\n* Have known primary CNS cancer.\n* Have known CNS metastases unless previously treated and well controlled for at least 1 month\n* Have concomitant second malignancies unless a complete remission was achieved at least 2 years before study entry\n* Have a history of Grade ≥ 2 pneumonitis, active autoimmune disease, or persistent immune-mediated toxicity caused by immune checkpoint inhibitor therapy of Grade ≥ 2\n* Have toxicity (except for alopecia) related to prior anti-cancer therapy and/or surgery unless the toxicity is either resolved, returned to baseline or Grade 1, or deemed irreversible.\n* Have uncontrolled or significant cardiovascular disease\n* Part 1: major surgery within 3 weeks before initiating treatment\n* Part 1: Have received prior radiotherapy within 2 weeks of start of study treatment\n* Part 2 (H\\&N cancer):\n* Have received prior immunotherapy with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, or anti-cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways).\n* Have received prior chemotherapy administered in the recurrent advanced or metastatic setting (except for systemic therapy completed \\> 6 months prior to screening if given as part of multimodal treatment for locally advanced disease)",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Iteos Clinical Trials",
          "affiliation": "iTeos Belgium SA",
          "role": "STUDY_DIRECTOR"
        }
      ],
      "locations": [
        {
          "facility": "University of California San Diego",
          "city": "San Diego",
          "state": "California",
          "zip": "92037",
          "country": "United States",
          "geoPoint": {
            "lat": 32.71571,
            "lon": -117.16472
          }
        },
        {
          "facility": "Hackensack University Medical Center",
          "city": "Bergen",
          "state": "New Jersey",
          "zip": "07601",
          "country": "United States",
          "geoPoint": {
            "lat": 40.72927,
            "lon": -74.0657
          }
        },
        {
          "facility": "GZA Ziekenhuizen campus Sint-Augustinus",
          "city": "Antwerp",
          "state": "Antwerp",
          "zip": "2610",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.22047,
            "lon": 4.40026
          }
        },
        {
          "facility": "Cliniques universitaires St Luc-UCL",
          "city": "Brussels",
          "zip": "1200",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.85045,
            "lon": 4.34878
          }
        },
        {
          "facility": "Jessa Ziekenhuis",
          "city": "Hasselt",
          "zip": "3500",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.93106,
            "lon": 5.33781
          }
        },
        {
          "facility": "UZ Leuven",
          "city": "Leuven",
          "zip": "3000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.87959,
            "lon": 4.70093
          }
        },
        {
          "facility": "CHU Helora",
          "city": "Mons",
          "zip": "7000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.45413,
            "lon": 3.95229
          }
        },
        {
          "facility": "Hôpital Saint André",
          "city": "Bordeaux",
          "zip": "33075",
          "country": "France",
          "geoPoint": {
            "lat": 44.84124,
            "lon": -0.58046
          }
        },
        {
          "facility": "CHU Caen",
          "city": "Caen",
          "zip": "14033",
          "country": "France",
          "geoPoint": {
            "lat": 49.18585,
            "lon": -0.35912
          }
        },
        {
          "facility": "Centre Georges Francois Leclerc",
          "city": "Dijon",
          "zip": "21079",
          "country": "France",
          "geoPoint": {
            "lat": 47.31344,
            "lon": 5.01391
          }
        },
        {
          "facility": "Clinique Victor Hugo",
          "city": "Le Mans",
          "zip": "72000",
          "country": "France",
          "geoPoint": {
            "lat": 48.0021,
            "lon": 0.20251
          }
        },
        {
          "facility": "Centre Oscar Lambret",
          "city": "Lille",
          "zip": "59000",
          "country": "France",
          "geoPoint": {
            "lat": 50.63391,
            "lon": 3.05512
          }
        },
        {
          "facility": "Centre Léon Bérard",
          "city": "Lyon",
          "zip": "69373",
          "country": "France",
          "geoPoint": {
            "lat": 45.74906,
            "lon": 4.84789
          }
        },
        {
          "facility": "Institut de Cancerologie Lorraine (ICL)",
          "city": "Nancy",
          "zip": "54519",
          "country": "France",
          "geoPoint": {
            "lat": 48.68439,
            "lon": 6.18496
          }
        },
        {
          "facility": "Institut de Cancérologie de l'Ouest",
          "city": "Nantes",
          "zip": "44805",
          "country": "France",
          "geoPoint": {
            "lat": 47.21725,
            "lon": -1.55336
          }
        },
        {
          "facility": "Centre Antoine Lacassagne",
          "city": "Nice",
          "zip": "06189",
          "country": "France",
          "geoPoint": {
            "lat": 43.70313,
            "lon": 7.26608
          }
        },
        {
          "facility": "Pitié Salpêtrière",
          "city": "Paris",
          "zip": "75013",
          "country": "France",
          "geoPoint": {
            "lat": 48.85341,
            "lon": 2.3488
          }
        },
        {
          "facility": "CHU de POITIERS",
          "city": "Poitiers",
          "zip": "86000",
          "country": "France",
          "geoPoint": {
            "lat": 46.58261,
            "lon": 0.34348
          }
        },
        {
          "facility": "ICANS",
          "city": "Strasbourg",
          "zip": "67033",
          "country": "France",
          "geoPoint": {
            "lat": 48.58392,
            "lon": 7.74553
          }
        },
        {
          "facility": "IDB Center-Istituto Clinico Humanitas (IRCCS)",
          "city": "Rozzano",
          "state": "Milan",
          "zip": "20089",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.38193,
            "lon": 9.1559
          }
        },
        {
          "facility": "FPO-IRCCS Candiolo Cancer Insitute",
          "city": "Candiolo",
          "state": "Turin",
          "zip": "10060",
          "country": "Italy",
          "geoPoint": {
            "lat": 44.95858,
            "lon": 7.59812
          }
        },
        {
          "facility": "Universita degli Studi di Pavia - Fondazione IRCCS Policlinico San Matteo",
          "city": "Pavia",
          "zip": "27100",
          "country": "Italy",
          "geoPoint": {
            "lat": 45.19205,
            "lon": 9.15917
          }
        },
        {
          "facility": "AUSL Della Romagna - Ospedale S. Maria delle Croci",
          "city": "Ravenna",
          "zip": "48121",
          "country": "Italy",
          "geoPoint": {
            "lat": 44.41344,
            "lon": 12.20121
          }
        },
        {
          "facility": "Hospital Althaia Xarxa Assitencial de Manresa",
          "city": "Manresa",
          "state": "Catalonia",
          "zip": "08243",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.72815,
            "lon": 1.82399
          }
        },
        {
          "facility": "Hospital Universitario de Badajoz",
          "city": "Badajoz",
          "zip": "06006",
          "country": "Spain",
          "geoPoint": {
            "lat": 38.87789,
            "lon": -6.97061
          }
        },
        {
          "facility": "Vall d'Hebron",
          "city": "Barcelona",
          "zip": "08035",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Hospital Universitario de Jaen",
          "city": "Jaén",
          "zip": "23007",
          "country": "Spain",
          "geoPoint": {
            "lat": 37.76922,
            "lon": -3.79028
          }
        },
        {
          "facility": "Hospital Clinico San Carlos",
          "city": "Madrid",
          "zip": "28040",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Hospital Universitario Fundación Jiménez Díaz - START Madrid",
          "city": "Madrid",
          "zip": "28040",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Hospital Universitario 12 de Octubre",
          "city": "Madrid",
          "zip": "28041",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Hospital Quirón Málaga",
          "city": "Málaga",
          "zip": "29004",
          "country": "Spain",
          "geoPoint": {
            "lat": 36.72016,
            "lon": -4.42034
          }
        },
        {
          "facility": "Hospital Universitario de Navarra",
          "city": "Pamplona",
          "zip": "31008",
          "country": "Spain",
          "geoPoint": {
            "lat": 42.81687,
            "lon": -1.64323
          }
        },
        {
          "facility": "Hospital Universitario Virgen Macarena",
          "city": "Seville",
          "zip": "41009",
          "country": "Spain",
          "geoPoint": {
            "lat": 37.38283,
            "lon": -5.97317
          }
        },
        {
          "facility": "Fundacion Instituto Valenciano de Oncologia (IVO)",
          "city": "Valencia",
          "zip": "46009",
          "country": "Spain",
          "geoPoint": {
            "lat": 39.47391,
            "lon": -0.37966
          }
        },
        {
          "facility": "Consorci Hospital Gral Univ Valencia",
          "city": "Valencia",
          "zip": "46014",
          "country": "Spain",
          "geoPoint": {
            "lat": 39.47391,
            "lon": -0.37966
          }
        },
        {
          "facility": "Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur)",
          "city": "Valencia",
          "zip": "46026",
          "country": "Spain",
          "geoPoint": {
            "lat": 39.47391,
            "lon": -0.37966
          }
        },
        {
          "facility": "Hospital Universitario Miguel Servet",
          "city": "Zaragoza",
          "zip": "50009",
          "country": "Spain",
          "geoPoint": {
            "lat": 41.65606,
            "lon": -0.87734
          }
        },
        {
          "facility": "Royal Marsden Hospital (Sutton location)",
          "city": "Sutton",
          "state": "Surrey",
          "zip": "SM2 5PT",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 51.35,
            "lon": -0.2
          }
        },
        {
          "facility": "Addenbrooke's Hospital",
          "city": "Cambridge",
          "zip": "CB2 0QQ",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 52.2,
            "lon": 0.11667
          }
        },
        {
          "facility": "Royal Marsden Hospital (London location)",
          "city": "London",
          "zip": "SW3 6JJ",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 51.50853,
            "lon": -0.12574
          }
        },
        {
          "facility": "Hammersmith Hospital",
          "city": "London",
          "zip": "W12 0HS",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 51.50853,
            "lon": -0.12574
          }
        },
        {
          "facility": "Nottingham City Hospital",
          "city": "Nottingham",
          "zip": "NG5 1PB",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 52.9536,
            "lon": -1.15047
          }
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "NO"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-02"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D008175",
          "term": "Lung Neoplasms"
        },
        {
          "id": "D006258",
          "term": "Head and Neck Neoplasms"
        },
        {
          "id": "D008545",
          "term": "Melanoma"
        }
      ],
      "ancestors": [
        {
          "id": "D012142",
          "term": "Respiratory Tract Neoplasms"
        },
        {
          "id": "D013899",
          "term": "Thoracic Neoplasms"
        },
        {
          "id": "D009371",
          "term": "Neoplasms by Site"
        },
        {
          "id": "D009369",
          "term": "Neoplasms"
        },
        {
          "id": "D008171",
          "term": "Lung Diseases"
        },
        {
          "id": "D012140",
          "term": "Respiratory Tract Diseases"
        },
        {
          "id": "D018358",
          "term": "Neuroendocrine Tumors"
        },
        {
          "id": "D017599",
          "term": "Neuroectodermal Tumors"
        },
        {
          "id": "D009373",
          "term": "Neoplasms, Germ Cell and Embryonal"
        },
        {
          "id": "D009370",
          "term": "Neoplasms by Histologic Type"
        },
        {
          "id": "D009380",
          "term": "Neoplasms, Nerve Tissue"
        },
        {
          "id": "D018326",
          "term": "Nevi and Melanomas"
        },
        {
          "id": "D012878",
          "term": "Skin Neoplasms"
        },
        {
          "id": "D012871",
          "term": "Skin Diseases"
        },
        {
          "id": "D017437",
          "term": "Skin and Connective Tissue Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "C582435",
          "term": "pembrolizumab"
        },
        {
          "id": "C000719628",
          "term": "dostarlimab"
        }
      ]
    }
  },
  "hasResults": false
}